Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP504306.RAnCZGJJVbnSq97xA7wDY5DbPhl3a7mjJh1nwC0OGrFY0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP504306.RAnCZGJJVbnSq97xA7wDY5DbPhl3a7mjJh1nwC0OGrFY0130_assertion type Assertion NP504306.RAnCZGJJVbnSq97xA7wDY5DbPhl3a7mjJh1nwC0OGrFY0130_head.
- NP504306.RAnCZGJJVbnSq97xA7wDY5DbPhl3a7mjJh1nwC0OGrFY0130_assertion description "[Moreover, IgAN patients as a whole exhibited a reduction of EGF and an increase of IL-6 urinary concentration (EGF values: N, 12.96 +/- 1.15; IgAN Grades 1-2, 20.05 +/- 2.64; Grades 3-4 7.60 +/- 1.70: Grade 5, 3.14 +/- 0.71, ng/mg urinary creatinine.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP504306.RAnCZGJJVbnSq97xA7wDY5DbPhl3a7mjJh1nwC0OGrFY0130_provenance.
- NP504306.RAnCZGJJVbnSq97xA7wDY5DbPhl3a7mjJh1nwC0OGrFY0130_assertion evidence source_evidence_literature NP504306.RAnCZGJJVbnSq97xA7wDY5DbPhl3a7mjJh1nwC0OGrFY0130_provenance.
- NP504306.RAnCZGJJVbnSq97xA7wDY5DbPhl3a7mjJh1nwC0OGrFY0130_assertion SIO_000772 8943482 NP504306.RAnCZGJJVbnSq97xA7wDY5DbPhl3a7mjJh1nwC0OGrFY0130_provenance.
- NP504306.RAnCZGJJVbnSq97xA7wDY5DbPhl3a7mjJh1nwC0OGrFY0130_assertion wasDerivedFrom befree-20140225 NP504306.RAnCZGJJVbnSq97xA7wDY5DbPhl3a7mjJh1nwC0OGrFY0130_provenance.
- NP504306.RAnCZGJJVbnSq97xA7wDY5DbPhl3a7mjJh1nwC0OGrFY0130_assertion wasGeneratedBy ECO_0000203 NP504306.RAnCZGJJVbnSq97xA7wDY5DbPhl3a7mjJh1nwC0OGrFY0130_provenance.